The 10,000 Brains Project is a nonprofit initiative dedicated to advancing targeted therapies for the millions of people affected by neurodegenerative diseases worldwide. By working across neurodegenerative diseases and harnessing the full potential of innovative tools and technologies, we aim to accelerate breakthroughs in earlier detection and more personalized care.
We envision a future where innovative technologies—such as artificial intelligence (AI) and big data analytics— unlock new insights across neurodegenerative disorders, enabling earlier detection and more personalized treatment for all patients.
Patrick Brannelly
CEO and Board Member
Mukta Phatak
Vice President of Data Strategy
Everett Cook
Co-Chair of the Board
Kathy Harvard
Board Member
David Kemp
Board Member and Treasurer
Oliver Kennan
Board Member and Secretary
Michael Maynard
Co-Chair of the Board
Ralph Terkowitz
Board Member
Professor of Pharmaceutical Chemistry
The University of California, San Francisco
Professor of Pathology and Neuroscience
The Icahn School of Medicine at Mount Sinai, NY
Executive Director
Chief Science Officer
CurePSP
Chief AI Officer
Eli Lilly and Company
Professor of Neurology
Chairman of Neurology
The Perelman School of Medicine at
the University of Pennsylvania
Professor of Neurology
Pathology Director
Boston University CTE Center
Director, Friedman Brain Institute
Chief Scientific Officer
The Icahn School of Medicine
at Mount Sinai, NY
Professor of Neurology and Pathology
The Memory and Aging Center
The University of California, San Francisco
Assistant Professor of Neuroscience at the Brain Science Institute
Associate Director of the JHU Single-Cell Training and Analysis Center
Johns Hopkins University
Scientific Director
Neural Stem Cell Institute University at Albany
State University of New York
Professor of Pharmaceutical Chemistry
The University of California, San Francisco